AnalysisNews

DBD today

$57.04-$0.30 (-0.52%)close Nov 11, 2026

Trend

DailyUptrend (starting)

4 hourSymmetric Triangle

1 hourBearish

15 minStrong Bearish

5 minExpanding

Daily trend turns down below $59.28

Key levels

Resistance$62.58

Resistance$59.28

Support$56.20

Support$52.87

Latest news & SEC filings

LegalDiebold Nixdorf Probed by Lawyers After It Cuts Forecast

AnalystWedbush trims its valuation view on Diebold Nixdorf to $90

AnalystWedbush keeps Outperform rating on Diebold Nixdorf, cuts target to $90

NewsDiebold Nixdorf approves $250 million stock buyback program

All DBD news →

About Diebold Nixdorf

Diebold Nixdorf provides banking and retail technology, including automated teller machines, self-service kiosks, point-of-sale systems, and related software and services. The company serves financial institutions and retailers. It operates in markets worldwide.

Based on the company's 10-K filed Feb 12, 2026.

NYSE · Technology

DIEBOLD NIXDORF, Inc (DBD)

$57.04-0.30 (-0.52%)
WATCHLISTGrade: A+Risk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
57.8960.7363.5866.4257.04Oct 9Oct 19Oct 27Nov 4
High59.23
Low56.77
Open58.19
Volume239K
Avg Vol294K
VWAP57.24
30d High69.26
30d Low55.05
30d Chg-9.72%

What Is the Price Target for DBD?

SEPT Low Target

$85.00

SEPT Mid Target

$100.00

SEPT High Target

$115.00

Analyst Consensus

$100.00

Current: $57.04Upside: +75.3%Confidence: 40%Method: Analyst Consensus

Is DBD a Buy or Sell Right Now?

86
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 1.5% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DBD.

Start Free Trial →

Is DBD Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$107.17

39

Moat Score

NONE

7/9

Piotroski Score

1.9

Altman Z-Score

What Is Smart Money Doing with DBD?

Insider Signal

NEUTRAL

4 buys / 6 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Millstreet Capital Management LLC10% ownerSale1,108$91KJun 11, 2026
Millstreet Capital Management LLC10% ownerSale17,660$1.4MJun 10, 2026
Millstreet Capital Management LLC10% ownerSale88,334$7.3MJun 8, 2026
Timko Thomas SofficerSale672-Jun 3, 2026
Marquez Octaviodirector officerBuy621$49KMay 27, 2026
Marquez Octaviodirector officerBuy629$50KMay 26, 2026
Myers JonathanofficerBuy1,360$100KMay 22, 2026
Parris Colin J.directorBuy2,621-May 22, 2026
Markus Maura A.directorBuy2,621-May 22, 2026
Timko Thomas SofficerBuy672$50KMay 22, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

DBD Growth Story

Revenue YoY

1.5%

3yr Revenue CAGR

3.2%

EPS Growth YoY

677.27%

FCF Growth YoY

N/A%

Revenue Trend

ACCELERATING

Dark Pool Trades for DBD

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for DBD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:26:06$57.043,387$$193KSELL
21:00:32$57.041,177$$67KSELL
21:00:31$57.041,369$$78KSELL
20:15:56$57.243,194$$183KSELL
17:30:13$57.451,875$$108KSELL

5 dark pool trades shown · $$629K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for DIEBOLD NIXDORF, Inc (DBD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (6 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

DBD — frequently asked questions

What is DBD stock price today?

DIEBOLD NIXDORF, Inc (DBD) is at $57.04, down 0.52% (-$0.30) at the Nov 11, 2026 close.

Why is DBD stock moving today?

Latest DBD news — Oct 29, 2026: Diebold Nixdorf Probed by Lawyers After It Cuts Forecast · Oct 29, 2026: Wedbush trims its valuation view on Diebold Nixdorf to $90

What is the DBD price target?

The average analyst price target for DBD is $100.00, ranging from $100 to $100, based on 1 analysts.

What do analysts rate DBD?

Analyst ratings for DBD: 0 Buy, 1 Hold, 0 Sell — consensus Hold.

Did DBD beat earnings?

DBD last reported on Oct 28, 2026: EPS $1.34 vs $1.31 expected — a beat of 2.3%.

What is DBD's P/E ratio?

DBD trades at a P/E of 19.3 vs a Technology average of 31.1.

Does DBD pay a dividend?

DBD does not currently pay a dividend.

What are DBD support and resistance levels?

Support: $56.20, $52.87, $47.34. Resistance: $59.28, $62.58, $65.74.

What are insiders doing with DBD?

Insider activity: NEUTRAL, 4 buys and 6 sells in the last 90 days.

What is the latest news on DBD?

Oct 29, 2026: Diebold Nixdorf Probed by Lawyers After It Cuts Forecast · Oct 29, 2026: Wedbush trims its valuation view on Diebold Nixdorf to $90 · Oct 29, 2026: Wedbush keeps Outperform rating on Diebold Nixdorf, cuts target to $90